CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Evotec AG is a global provider of drug discovery and development solutions to the pharmaceutical and biotechnology industries, academics, foundations, and venture capitalists. The company’s primary areas of expertise are neuroscience, oncology, diabetes, inflammation, pain and infections.
Evotec AG divides their operations into two key segments: EVT Execute and EVT Innovate. Their sites of operation can be found in Germany, France, the UK, and the US. Their main office is located in Hamburg, Germany.
Evotek share price info: Evotek stock is listed on the Frankfurt Stock Exchange. You can learn more about Evotek stock price with the Capital.com app.
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.